Published in Immunology on July 10, 2017
Multiple sclerosis. Lancet (2008) 13.77
Taking dendritic cells into medicine. Nature (2007) 11.82
Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med (2009) 3.38
Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity (2008) 2.78
Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells. J Immunol (2004) 2.77
The ins and outs of leukocyte integrin signaling. Annu Rev Immunol (2009) 2.76
Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol (2010) 1.91
Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis. J Immunol (2009) 1.64
Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol Dial Transplant (2006) 1.49
Regulatory B cells: origin, phenotype, and function. Immunity (2015) 1.47
T(H)17 cytokines in autoimmune neuro-inflammation. Curr Opin Immunol (2011) 1.40
The role of antigen presenting cells in multiple sclerosis. Biochim Biophys Acta (2010) 1.38
Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE. CNS Neurosci Ther (2013) 1.07
Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions. Cancer Immunol Res (2015) 1.05
CD83: a regulatory molecule of the immune system with great potential for therapeutic application. J Med Dent Sci (2006) 0.97
Beneficial effect of tolerogenic dendritic cells pulsed with MOG autoantigen in experimental autoimmune encephalomyelitis. CNS Neurosci Ther (2014) 0.90
Multiple Sclerosis and T Lymphocytes: An Entangled Story. J Neuroimmune Pharmacol (2015) 0.89
Signal transduction pathways of inflammatory gene expressions and therapeutic implications. Curr Pharm Des (2006) 0.88
Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort. Mediators Inflamm (2015) 0.87
A basic overview of multiple sclerosis immunopathology. Eur J Neurol (2015) 0.86
Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis. Mediators Inflamm (2013) 0.86
Adaptor regulation of LFA-1 signaling in T lymphocyte migration: Potential druggable targets for immunotherapies? Eur J Immunol (2014) 0.84
Tolerogenic dendritic cells and their applications in transplantation. Cell Mol Immunol (2014) 0.84
Vitamin D and multiple sclerosis. J Clin Neurosci (2013) 0.83
PD-1/PD-L and autoimmunity: A growing relationship. Cell Immunol (2016) 0.82
Cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis: therapeutic implications. Neuroimmunomodulation (2014) 0.82
The Role of Chemokines in Shaping the Balance Between CD4(+) T Cell Subsets and Its Therapeutic Implications in Autoimmune and Cancer Diseases. Front Immunol (2015) 0.81
Illuminating vitamin D effects on B cells - the multiple sclerosis perspective. Immunology (2016) 0.81
The Dendritic Cell Synapse: A Life Dedicated to T Cell Activation. Front Immunol (2016) 0.80
Circulating immune cells in multiple sclerosis. Clin Exp Immunol (2016) 0.80
Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications. Immune Netw (2016) 0.80
1,25-Dihydroxyvitamin D3-Conditioned CD11c+ Dendritic Cells are Effective Initiators of CNS Autoimmune Disease. Front Immunol (2015) 0.77
B cells in MS: Why, where and how? Mult Scler Relat Disord (2012) 0.77
Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1. Immunol Lett (2015) 0.77
B-cell modulation of dendritic-cell function: signals from the far side. Eur J Immunol (2014) 0.76